Petr Smíšek

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Gertjan J.L. Kaspers, Martin Zimmermann, Dirk Reinhardt et al. · Journal of Clinical Oncology · 2013 · 234 citations

Medicine, Hematology, Oncology +17

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

Ursula Creutzig, Martin Zimmermann, Michael Dworzak et al. · Haematologica · 2014 · 48 citations · Full text

Medicine, Hematology, Oncology +15

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

Maria Elena Maccari, Sebastian Fuchs, Patrick Küry et al. · The Journal of Experimental Medicine · 2020 · 48 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

Carmelo Rizzari, Claudia Lanvers‐Kaminsky, Maria Grazia Valsecchi et al. · Haematologica · 2019 · 44 citations · Full text

Medicine, Pediatrics, Pharmacology +15

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated <i>E. coli</i> asparaginase in children with acute lymphocytic leukemia

Alaeddin Khalil, Gudrun Würthwein, Jana Golitsch et al. · Haematologica · 2020 · 44 citations · Full text

Medicine, Immunology, Pediatrics +12